| Primary |
| Constipation |
37.5% |
| Blood Cholesterol Increased |
12.5% |
| Depression |
12.5% |
| Hypertension |
12.5% |
| Schizophrenia |
12.5% |
| Stools Hard |
12.5% |
|
| Completed Suicide |
20.0% |
| Nausea |
20.0% |
| Oral Discomfort |
20.0% |
| Respiratory Distress |
20.0% |
| White Blood Cell Count Increased |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
25.7% |
| Constipation |
10.8% |
| Systemic Lupus Erythematosus |
10.3% |
| Drug Use For Unknown Indication |
8.0% |
| Schizophrenia |
7.2% |
| Hypertension |
6.1% |
| Blood Cholesterol Increased |
5.5% |
| Type 2 Diabetes Mellitus |
5.3% |
| Anxiety |
5.1% |
| Depression |
5.1% |
| Drug Exposure During Pregnancy |
1.8% |
| Atrial Fibrillation |
1.3% |
| B Precursor Type Acute Leukaemia |
1.3% |
| Precursor T-lymphoblastic Lymphoma/leukaemia |
1.1% |
| Schizophrenia, Paranoid Type |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Osteoporosis |
1.0% |
| Cellulitis |
0.8% |
| Medical Diet |
0.8% |
| Suicide Attempt |
0.8% |
|
| White Blood Cell Count Increased |
28.1% |
| Teratogenicity |
14.9% |
| Drug Level Increased |
6.1% |
| Non-hodgkin's Lymphoma |
6.1% |
| Diarrhoea |
5.3% |
| Completed Suicide |
3.5% |
| Dizziness |
3.5% |
| Drug Exposure During Pregnancy |
3.5% |
| Overdose |
3.5% |
| Toxicity To Various Agents |
3.5% |
| Vomiting |
3.5% |
| Deep Vein Thrombosis |
2.6% |
| Loss Of Consciousness |
2.6% |
| Maternal Drugs Affecting Foetus |
2.6% |
| Drug Toxicity |
1.8% |
| Irritable Bowel Syndrome |
1.8% |
| Medication Error |
1.8% |
| Purpura |
1.8% |
| Urinary Tract Infection |
1.8% |
| Ventricular Extrasystoles |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.9% |
| Drug Use For Unknown Indication |
23.2% |
| Constipation |
9.1% |
| Pain |
7.2% |
| Hypertension |
3.7% |
| Multiple Myeloma |
3.1% |
| Nausea |
3.0% |
| Depression |
2.5% |
| Prophylaxis |
2.3% |
| Non-small Cell Lung Cancer |
1.8% |
| Schizophrenia |
1.8% |
| Anxiety |
1.7% |
| Rheumatoid Arthritis |
1.3% |
| Insomnia |
1.2% |
| Vomiting |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Diabetes Mellitus |
1.0% |
| Adverse Event |
1.0% |
| Diffuse Large B-cell Lymphoma |
1.0% |
| Breast Cancer |
0.9% |
|
| Vomiting |
17.3% |
| Weight Decreased |
11.1% |
| White Blood Cell Count Increased |
7.5% |
| Urinary Tract Infection |
6.0% |
| Thrombocytopenia |
5.2% |
| Death |
4.9% |
| Pneumonia |
4.8% |
| Pulmonary Embolism |
4.6% |
| Tremor |
4.4% |
| Renal Failure Acute |
4.2% |
| Pyrexia |
4.0% |
| Syncope |
3.5% |
| Nausea |
3.3% |
| Unresponsive To Stimuli |
3.1% |
| Respiratory Failure |
3.0% |
| White Blood Cell Count Decreased |
2.9% |
| Sepsis |
2.8% |
| Vision Blurred |
2.6% |
| Rash |
2.5% |
| Malaise |
2.4% |
|
| Interacting |
| Obesity |
11.4% |
| Antibiotic Prophylaxis |
9.1% |
| Back Pain |
9.1% |
| Constipation |
9.1% |
| Hiv Infection |
9.1% |
| Premedication |
6.8% |
| Antifungal Prophylaxis |
4.5% |
| Chronic Lymphocytic Leukaemia |
4.5% |
| Hypertension |
4.5% |
| Pain |
4.5% |
| Phytotherapy |
4.5% |
| Weight Decreased |
4.5% |
| Autoimmune Thrombocytopenia |
2.3% |
| Basedow's Disease |
2.3% |
| Bk Virus Infection |
2.3% |
| Escherichia Bacteraemia |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Hyperlipidaemia |
2.3% |
| Infection Prophylaxis |
2.3% |
| Neutropenia |
2.3% |
|
| Vomiting |
33.3% |
| Discomfort |
16.7% |
| Hyperkalaemia |
16.7% |
| Liver Transplant |
16.7% |
| Restlessness |
16.7% |
|